BSEBoard Meeting1d ago · 11 Aug 2026, 05:46 pm

Outcome of the 2/2026-27 Meeting of the Board of Directors of the Company held on Tuesday, 11th August 2026 pursuant to Regulation 30 read with Schedule III(A)(IV) of the SEBI(LODR) Regulations, 2015.

Syncom Formulations India Ltd-$ · 524470

✦ AI SummaryResults

Syncom Formulations India Ltd's board meeting outcome announced, with approval of unaudited financial results, limited review report, and other business matters. Resignations of directors and appointments of new directors and CFO. Final dividend recommendation and record date set.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Syncom Formulations India Ltd-$ - 524470 - Board Meeting Outcome for Outcome Of The 2/2026-27 Meeting Of The Board Of Directors Of The Company.

Attachments (1)

📄

22fab449-8d97-4d29-8f46-ff33e5041a3e.pdf

pdf

Download →
View document text
SYNCOM/SE/2026-27 11th August, 2026 Online filing at: www.listing.bseindia.com and https://neaps.nseindia.com/NEWLISTINGCORP/login.jsp To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Tower, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai (M.H.) 400 001 Mumbai- 400051 BSE CODE:524470 NSE SYMBOL: SYNCOMF Sub: Outcome of the 2/2026-27 Meeting of the Board of Directors of the Company held on Tuesday, 11th August 2026 pursuant to Regulation 30 read with Schedule III(A)(IV) of the SEBI(LODR) Regulations, 2015. Dear Sir/Madam, This has in reference to our earlier communication vide letter No. SYNCOM/SE/2026-27 dated 6th August, 2026 intimating the notice of the 2/2026-27 Meeting of the board of Directors of the Company, pursuant to Regulation 29(1)(a) and Regulation 30 of SEBI (LODR) Regulations,2015 read with Schedule III of the said Regulation. We would like to inform that the Board of Directors of the Company, at its Meeting held on Tuesday, 11th August, 2026 at 4:00 P.M., has considered and approved the following business:- 1. Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter ended 30th June, 2026. 2. Taken on record the Limited Review Report by the Auditors for the Standalone and Consolidated Financial results of the company for the Quarter ended 30th June, 2026. 3. Approval for the Board’s Report and Notice of the 38th Annual General Meeting (AGM) to be held on Wednesday the 30th day of September, 2026 at 2:00 P.M. through Video Conferencing / Other Audio-Visual Means (VC/OAVM). 4. Finalization of the Annual Book Closure of the Company for the 38th AGM. 5. Finalization of the Cut-off Date for determining eligibility for participation in the Remote E- voting and E-voting process at the 38th AGM. 6. Appointment of Scrutinizer for the conducting Remote E-voting as well as E-voting process at 38th AGM. 7. Appointment of Cost Auditor and the remuneration will be subject to ratification of the shareholder at the ensuing AGM. 8. Appointment of Internal Auditor of the Company. 9. Noting the resignation of Shri Kedarmal Shankarlal Bankda (DIN: 00023050) from the position of Whole-time Director with effect from the close of business hours on August 11, 2026. 10. Noting the resignation of Shri Vijay Shankarlal Bankda (DIN: 00023027) from the position of Managing Director with effect from the close of business hours on August 11, 2026. 11. Noting resignation of Shri Rahul Vijay Bankda from the position of Chief Financial Officer (CFO), with effect from the close of business hours on August 11, 2026. 12. Approved the appointment of Mrs. Rinki Ankit Bankda (DIN: 06946754) as an Additional Director and further designated as Whole Time Director of the Company, with effect from August 12, 2026, subject to approval of members within in a period of 3 months from the date of appointment. 13. Approval for the appointment of Shri Rahul Vijay Bankda (DIN: 00827827) as an Additional Director and further designated as Managing Director of the Company, with effect from August 12, 2026, subject to approval of members within in a period of 3 months from the date of appointment. 14. Approval for the appointment of Shri Ankur Vijay Bankda (DIN: 02328515) as Chief Financial Officer (CFO) of the Company, with effect from August 12, 2026. 15. Approval for reappointment for Smt. Ruchi Jindal (DIN: 09633465) as Woman Independent Director of the company with effect from 29th June, 2027 subject to approval of members in the ensuing AGM. 16. Recommendation of the Final dividend of Re. 0.10/- (@ 10%) per equity share of Re. 1/- each, subject to approval of the shareholders at the AGM. The Record Date as Wednesday, September 23, 2026, in compliance with regulation 42(1) of the Listing Regulations, to determine the list of shareholders entitled to receive the final dividend for the Financial Year ended on March 31, 2026, payment of which shall be subject to the approval by the members at the AGM. Details of the same is provided in Annexure 1 17. Consideration of other routine business matters. The Board Meeting commenced at 4:00 P.M. and concluded at 04:45 P.M. You are requested to please take on record our above said information for your reference and record and disseminate on the portal of the BSE and NSE for information to the investors and members of the Company. Thanking you, Yours faithfully, For, SYNCOM FORMULATIONS (INDIA) LIMITED CS VAISHALI AGRAWAL COMPANY SECRETARY & COMPLIANCE OFFICER Annexure 1 Symbol / Type of Record Date Purpose Security Code Security SYNCOMF Equity Share 23.09.2026 For payment of final dividend @ 10% i.e. Rs. 0.10/- per Equity Share of the Company for the year ended 31" March 2026, if approved by the Shareholders of the Company in the ensuing Annual General Meeting.